Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Berman

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of Virology|December 1, 1987
T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzeesJ W Eichberg, J M Zarling, H J Alter, et al.
Journal of Cellular Biochemistry|October 28, 1999
Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activatorC Köhne, A Johnson, S Tom, et al.
Journal of Virology|October 1, 1993
Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1G R Nakamura, R Byrn, D M Wilkes, et al.
AIDS Research and Human Retroviruses|November 14, 1998
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3D P Francis, T Gregory, M J McElrath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1W A Werther, T N Gonzalez, S J O'Connor, et al.
Nature|June 14, 1990
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160P W Berman, T J Gregory, L Riddle, et al.
Science (New York, N.Y.)|July 11, 1986
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoproteinL A Lasky, J E Groopman, C W Fennie, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
The Journal of Infectious Diseases|January 1, 1996
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1P W Berman, K K Murthy, T Wrin, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Virology|December 1, 1987
T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzeesJ W Eichberg, J M Zarling, H J Alter, et al.
Journal of Cellular Biochemistry|October 28, 1999
Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activatorC Köhne, A Johnson, S Tom, et al.
Journal of Virology|October 1, 1993
Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1G R Nakamura, R Byrn, D M Wilkes, et al.
AIDS Research and Human Retroviruses|November 14, 1998
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3D P Francis, T Gregory, M J McElrath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1W A Werther, T N Gonzalez, S J O'Connor, et al.
Nature|June 14, 1990
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160P W Berman, T J Gregory, L Riddle, et al.
Science (New York, N.Y.)|July 11, 1986
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoproteinL A Lasky, J E Groopman, C W Fennie, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
The Journal of Infectious Diseases|January 1, 1996
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1P W Berman, K K Murthy, T Wrin, et al.
Pageof 6